These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
441 related articles for article (PubMed ID: 25692632)
1. Transoral robotic surgery for oropharyngeal squamous cell carcinoma. Schmitt NC; Duvvuri U Curr Opin Otolaryngol Head Neck Surg; 2015 Apr; 23(2):127-31. PubMed ID: 25692632 [TBL] [Abstract][Full Text] [Related]
2. The Role of Transoral Robotic Surgery in the Management of HPV Negative Oropharyngeal Squamous Cell Carcinoma. Sload R; Silver N; Jawad BA; Gross ND Curr Oncol Rep; 2016 Sep; 18(9):53. PubMed ID: 27469262 [TBL] [Abstract][Full Text] [Related]
3. Oropharyngeal cancer treatment: the role of transoral surgery. Hinni ML; Nagel T; Howard B Curr Opin Otolaryngol Head Neck Surg; 2015 Apr; 23(2):132-8. PubMed ID: 25761152 [TBL] [Abstract][Full Text] [Related]
4. Making a case for high-volume robotic surgery centers: A cost-effectiveness analysis of transoral robotic surgery. Rudmik L; An W; Livingstone D; Matthews W; Seikaly H; Scrimger R; Marshall D J Surg Oncol; 2015 Aug; 112(2):155-63. PubMed ID: 26171771 [TBL] [Abstract][Full Text] [Related]
5. Transoral robotic versus open surgical approaches to oropharyngeal squamous cell carcinoma by human papillomavirus status. Ford SE; Brandwein-Gensler M; Carroll WR; Rosenthal EL; Magnuson JS Otolaryngol Head Neck Surg; 2014 Oct; 151(4):606-11. PubMed ID: 25049265 [TBL] [Abstract][Full Text] [Related]
6. Functional outcomes, feasibility, and safety of resection of transoral robotic surgery: single-institution series of 35 consecutive cases of transoral robotic surgery for oropharyngeal squamous cell carcinoma. Lörincz BB; Möckelmann N; Busch CJ; Knecht R Head Neck; 2015 Nov; 37(11):1618-24. PubMed ID: 24955923 [TBL] [Abstract][Full Text] [Related]
7. Oncologic outcomes and patient-reported quality of life in patients with oropharyngeal squamous cell carcinoma treated with definitive transoral robotic surgery versus definitive chemoradiation. Ling DC; Chapman BV; Kim J; Choby GW; Kabolizadeh P; Clump DA; Ferris RL; Kim S; Beriwal S; Heron DE; Duvvuri U Oral Oncol; 2016 Oct; 61():41-6. PubMed ID: 27688103 [TBL] [Abstract][Full Text] [Related]
8. Outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery versus definitive chemoradiation. Dhanireddy B; Burnett NP; Sanampudi S; Wooten CE; Slezak J; Shelton B; Shelton L; Shearer A; Arnold S; Kudrimoti M; Gal TJ Am J Otolaryngol; 2019; 40(5):673-677. PubMed ID: 31201038 [TBL] [Abstract][Full Text] [Related]
9. Transoral robotic surgery vs. radiotherapy for management of oropharyngeal squamous cell carcinoma - A systematic review of the literature. Yeh DH; Tam S; Fung K; MacNeil SD; Yoo J; Winquist E; Palma DA; Nichols AC Eur J Surg Oncol; 2015 Dec; 41(12):1603-14. PubMed ID: 26461255 [TBL] [Abstract][Full Text] [Related]
10. Adoption of transoral robotic surgery compared with other surgical modalities for treatment of oropharyngeal squamous cell carcinoma. Cracchiolo JR; Roman BR; Kutler DI; Kuhel WI; Cohen MA J Surg Oncol; 2016 Sep; 114(4):405-11. PubMed ID: 27392812 [TBL] [Abstract][Full Text] [Related]
11. Functional outcomes after transoral robotic surgery for squamous cell carcinoma of the oropharynx. Van der Vorst S; Prasad V; Remacle M; Bachy V; Lawson G B-ENT; 2015; Suppl 24():15-9. PubMed ID: 26891527 [TBL] [Abstract][Full Text] [Related]
12. The role of transoral robotic surgery in the management of oropharyngeal squamous cell carcinoma: a current review. Sansoni ER; Gross ND Curr Oncol Rep; 2015 Mar; 17(3):432. PubMed ID: 25687805 [TBL] [Abstract][Full Text] [Related]
13. The impact of transoral robotic surgery on the overall treatment of oropharyngeal cancer patients. Smith RV; Schiff BA; Garg M; Haigentz M Laryngoscope; 2015 Nov; 125 Suppl 10():S1-S15. PubMed ID: 26436491 [TBL] [Abstract][Full Text] [Related]
14. A prospective evaluation of short-term dysphagia after transoral robotic surgery for squamous cell carcinoma of the oropharynx. Albergotti WG; Jordan J; Anthony K; Abberbock S; Wasserman-Wincko T; Kim S; Ferris RL; Duvvuri U Cancer; 2017 Aug; 123(16):3132-3140. PubMed ID: 28467606 [TBL] [Abstract][Full Text] [Related]
15. Decision management in transoral robotic surgery: Indications, individual patient selection, and role in the multidisciplinary treatment for head and neck cancer from a European perspective. Lörincz BB; Jowett N; Knecht R Head Neck; 2016 Apr; 38 Suppl 1():E2190-6. PubMed ID: 25833809 [TBL] [Abstract][Full Text] [Related]
16. Outcomes of transoral robotic surgery for early-stage oropharyngeal squamous cell carcinoma with low rates of adjuvant therapy: A consecutive single-institution study from 2013 to 2020. Meldgaard Justesen M; Kronberg Jakobsen K; Fenger Carlander AL; Hjordt Holm Larsen M; Wessel I; Kiss K; Friborg J; Ibrahim Channir H; Rubek N; Grønhøj C; von Buchwald C Oral Oncol; 2024 May; 152():106783. PubMed ID: 38569317 [TBL] [Abstract][Full Text] [Related]
17. Assessment of Surgical Learning Curves in Transoral Robotic Surgery for Squamous Cell Carcinoma of the Oropharynx. Albergotti WG; Gooding WE; Kubik MW; Geltzeiler M; Kim S; Duvvuri U; Ferris RL JAMA Otolaryngol Head Neck Surg; 2017 Jun; 143(6):542-548. PubMed ID: 28196200 [TBL] [Abstract][Full Text] [Related]
18. Transoral robotic surgery-based therapy in patients with stage III-IV oropharyngeal squamous cell carcinoma. Park YM; Kim HR; Cho BC; Keum KC; Cho NH; Kim SH Oral Oncol; 2017 Dec; 75():16-21. PubMed ID: 29224814 [TBL] [Abstract][Full Text] [Related]
19. Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS). Cannon RB; Houlton JJ; Patel S; Raju S; Noble A; Futran ND; Parvathaneni U; Méndez E Oral Oncol; 2018 Nov; 86():296-300. PubMed ID: 30409315 [TBL] [Abstract][Full Text] [Related]
20. Primary transoral robotic surgery with concurrent neck dissection for early stage oropharyngeal squamous cell carcinoma implemented at a Danish head and neck cancer center: a phase II trial on feasibility and tumour margin status. Rubek N; Channir HI; Charabi BW; Lajer CB; Kiss K; Nielsen HU; Bentzen J; Friborg J; von Buchwald C Eur Arch Otorhinolaryngol; 2017 May; 274(5):2229-2237. PubMed ID: 28050651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]